Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V für die im Rahmen des Sprechstundenbedarfs in Niedersachsen verordnungs- und abgabefähigen Arzneimittel mit dem Wirkstoff Dexamethason (ATC-Code: H02AB02).

Conclusion of a non-exclusive discount contract in accordance with § 130a paragraph 8 SGB V for the prescription and dispensing of medicines with the active substance Dexamethasone (ATC code: H02AB02) within the period from 01.09.2026 to 31.08.2028, with the possibility of concluding the contract at any time during the term (“open-house model”). In Lower Saxony, pharmacies are required to dispense finished medicinal products for which a discount contract in accordance with § 130a paragraph 8 SGB V exists, in the event of a prescription requirement, as of 01.07.2026.